Home › Funds › Groupe la Francaise › AZN
Groupe la Francaise position in AZN
ASTRAZENECA PLC · Health Care
Groupe la Francaise reported holding 410,162 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$66.7M, representing 1.01% of its reported portfolio and ranking #23 among its reported holdings. Groupe la Francaise has disclosed AZN holdings in 4 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Groupe la Francaise's AZN position evolved
Groupe la Francaise first disclosed a stake in AZN in Q3 2025 at 130 shares (US$8K). The position peaked in Q1 2026 at 984,608 shares, worth US$190.8M. Across 4 filings, Groupe la Francaise increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 410,162 shares valued at US$66.7M — a reduction of -400,570 shares quarter over quarter.. Notable position changes include a 49% trim in Q3 2026 (shares rose 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 130 | $8.21K | New |
| Q1 2026 | 984.61K | $190.80M | New |
| Q2 2026 | 810.73K | $151.60M | Reduce |
| Q3 2026 | 410.16K | $66.67M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AZN and 13F data
AZN (ASTRAZENECA PLC) is a Health Care company. 68 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Capital International Investors (US$6.49B), Norges Bank Investment Management (US$6.33B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AZN
- INVESTOR AB 51.59M sh · $9.78B · Q2 2026
- Capital International Investors 34.58M sh · $6.49B · Q2 2026
- Norges Bank Investment Management 33.86M sh · $6.33B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Wellington Management Group 28.54M sh · $5.36B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 28.54M sh · $5.36B · Q2 2026
- Legal & General Investment Management America 25.75M sh · $4.82B · Q2 2026
- VANGUARD ASSET MANAGEMENT, Ltd 18.71M sh · $3.49B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 18.10M sh · $3.43B · Q2 2026
- PRUDENTIAL PLC 170.57K sh · $3.19B · Q2 2026
- Amundi US 16.42M sh · $3.11B · Q2 2026
More on Groupe la Francaise
FAQ
How long has Groupe la Francaise held AZN?
Groupe la Francaise has disclosed AZN holdings in 4 of the last 5 reported quarters, going back to Q3 2025.
What is Groupe la Francaise's current position in AZN?
As of Q3 2026, Groupe la Francaise holds 410.16K shares of AZN (ASTRAZENECA PLC), valued at $66.67M, representing 1.01% of its reported portfolio and ranking #23.
Has Groupe la Francaise been buying or selling AZN?
In the latest 13F filing (Q3 2026), Groupe la Francaise reduced its position in AZN. The position peaked in Q1 2026 at 984.61K shares.
Which other funds hold AZN?
Other major institutional holders of AZN include INVESTOR AB, Capital International Investors, Norges Bank Investment Management, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.